Clinical Research Directory
Browse clinical research sites, groups, and studies.
Prostate Cancer Detection Using the Stockholm3 Test and MR/Fusion Biopsies
Sponsor: Karolinska Institutet
Summary
The STHLM3-MRI trial is a study comparing traditional prostate cancer detection using PSA and systematic biopsies with the improved pipeline for prostate cancer detection using the STHLM3 test and targeted biopsies in a screening context. The study includes individualised repeat invitations for re-screening to participants not diagnosed with prostate cancer.
Official title: STHLM3 MR Phase 2: A New Diagnostic Chain for Prostate Cancer Detection Using the Stockholm3 Test and MR/Fusion Biopsies
Key Details
Gender
MALE
Age Range
50 Years - 74 Years
Study Type
INTERVENTIONAL
Enrollment
12750
Start Date
2018-04-04
Completion Date
2030-12-10
Last Updated
2023-12-26
Healthy Volunteers
Yes
Conditions
Interventions
MRI/Fusion biopsies
The intervention in the experimental arm is an MRI with targeted biopsies using fusion technique to prostate lesions. Repeat screening is offered after 2-6 years on an individualised basis.
Systematic biopsies
The intervention in the control arm is traditional systematic biopsies of the prostate.
Locations (3)
C-medical Odenplan Urology
Stockholm, Sweden
Capio St Görans Hospital
Stockholm, Sweden
Urologifocus
Stockholm, Sweden